Workshop 2019 Vendors
To participate as a vendor at the DPAI 3.0 Workshop please download and complete the application.
Contact Nova Marie Smith with any questions.
Ibex is the pioneer in applying computational pathology to cancer diagnostics. Based out of Tel Aviv, Israel, the company's machine learning experts, data scientists and pathologists use artificial intelligence (AI) to develop clinical grade algorithms that can detect prostate cancer as accurately as a human pathologist.
Pathologists are challenged to provide accurate and timely analysis as the number of tests increases year-over-year. In an effort to improve their workflow, pathology labs are starting to adopt digital technologies, including AI-based analysis of biopsies. Ibex's algorithms analyzes biopsy images, detects cancerous cells, grades them and can also detect other clinically significant features. The analysis is presented to pathologists either before or after reviewing the case, helping them in reducing error rates and improving operational efficiency by reducing the average time spent on a case.
Deployed in Israel, Europe and the United States, Ibex's solution is the first-ever AI-based cancer diagnosis solution in routine clinical use in a pathology lab and has already demonstrated success in detecting missed cancer cases. The first application Ibex released is for prostate and breast and it works on expanding to additional tissues. Ibex recently raised $15 million from prominent VC funds and corporate investors.
Visiopharm is a world leader in Augmented Pathology solutions; that comprise precision pathology and high-throughput pathology for tissue-diagnostics and research.
Leading biopharmaceutical companies, contract research organizations (CRO), academic medical centers, and diagnostic pathology labs all over the world utilize the Oncotopix platform for tissue-based research and diagnostics. The newest advancements in artificial intelligence and deep learning further consolidates Oncotopix as the most comprehensive and highly configurable solution for tissue analysis on the market today.
Our solutions are featured in over 1300 peer-reviewed scientific publications compatible with leading slide scanner manufacturers and data management software. Visiopharm is certified according to EN ISO 13485:2016, covering design, development, manufacture, installation, and service of in vitro diagnostics pathology software.
Our headquarters is in the Medicon Valley of Denmark, with a branch office in the United Kingdom, and a North American office in Westminster, Colorado.
Inspirata, Inc. helps patients fighting cancer -- and the clinicians they trust -- to make every moment matter. Our comprehensive cancer informatics solutions bring disparate data together throughout the entire cancer care journey to drive informed decisions that improve survivorship.
Inspirata has assembled the most advanced and proven technologies to address the complex challenges of delivering cancer care and conducting ground-breaking research. We combine leading digital pathology solutions with automated cancer registry solutions, comprehensive cancer informatics and advanced patient engagement tools to bring users the broadest oncology informatics platform available globally. For more information, please visit www.inspirata.com.
Leica Biosystems is a global leader in workflow solutions and automation, integrating each step in the process. As the only company to own the workflow from biopsy to diagnosis, we are uniquely positioned to break down the barriers between each of these steps. Our easy-to-use and consistently reliable offerings help improve workflow efficiency and diagnostic confidence.
Over the last ten years, new technology has enabled pathology departments to begin digitizing their work. Based on this trend, Sectra has developed Digital Pathology Solutions for the next generation consisting of a high-end diagnostic viewer, unified integrations, and proven archiving and image handling protocols. With full focus on end-user experience and workflow efficiency, pathologists are able to make their diagnoses and reporting faster and easier through efficient image interaction, access to full case overview any time, from anywhere, as well as easy image sharing for external review and a balanced workload.
With more than 20 years in imaging, Sectra develops andsells IT systems for radiology, pathology, women's health and orthopedics. More than 1,800 hospitals, clinics and imaging centers worldwide use the systems daily, making Sectra one of the world-leading companies for handling digital images. For more information visit https://medical.sectra.com
Gestalt Diagnostics has developed PathFlow, an enterprise software platform specifically designed to bring digital pathology and its benefits of automated, robust workflow to pathologists and pathology laboratories. This product was originally developed, by what is now Gestalts team, to support a robust PACS and workflow platform for radiology which is used for over 15 million reads today. In addition, Gestalt provides a Pathologist's Cockpit which includes image analysis, their worklist, a universal viewer, integration with any (and multiple) LIS's for full patient and case information, integrated reporting and voice recognition. We provide a unified platform for the Pathologist to maximize workflow, speed, accuracy and efficiency.
Mikroscan is committed to partnering with the pathology community by providing technology-enabled products and services which increase pathologists reach, remove barriers to workload efficiency, and enable new discoveries. Our solutions are utilized in hospitals, clinics, universities, and research institutions all over the world. From Frozen Section Support and Assessment of Adequacy of FNAs to Secondary Consultations, our technology serves a variety of robotic microscopy applications in anatomic pathology, veterinary pathology, teaching, and research settings. Mikroscan has ensured location no longer prevents the proper expertise from delivering the proper care. This is distributed pathology; this is the future.